Source:http://linkedlifedata.com/resource/pubmed/id/15477298
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-10-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0923-7534
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15 Suppl 4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
iv141-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15477298-Cancer Vaccines,
pubmed-meshheading:15477298-Clinical Trials as Topic,
pubmed-meshheading:15477298-Cytoplasmic Vesicles,
pubmed-meshheading:15477298-Dendritic Cells,
pubmed-meshheading:15477298-Humans,
pubmed-meshheading:15477298-Immunotherapy,
pubmed-meshheading:15477298-Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
Exosomes for cancer immunotherapy.
|
pubmed:affiliation |
Department of Medicine, Institut Gustave Roussy, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Review
|